Article
Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice.
European journal of pharmacology - 7 Feb 2003
Kelley Stephen P, Bratt Alison M, Hodge Clyde W
Abstract excerpt
Anxiety disorders are the most common psychiatric disorders. Typical medications used to treat patients are benzodiazepines or antidepressants that target serotonin (5-HT) activity. The ionotropic 5-HT(3) receptor has emerged as a potential therapeutic target because selective antagonist compounds reduce anxiety in rodents, primates, and humans. 5-HT binds to the extracellular N-terminus of the 5-HT(3A) receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
